SCHEMBL19199347

SCHEMBL19199347

c1ccc(-c2ccc(-c3c4ccccc4c(-c4cccc5c4ccc4ccccc45)c4ccccc34)cc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPRT1 P00492 3/20 0.50
SOS1 Q07889 1/20 0.45
ALDH1A1 P00352 4/20 0.45
TP53 P04637 2/20 0.45
HPGD P15428 2/20 0.45
MAPK1 P28482 2/20 0.45
LMNA P02545 2/20 0.45
HIF1A Q16665 2/20 0.45
MEN1 O00255 1/20 0.45
USP2 O75604 1/20 0.45
CYP1A2 P05177 1/20 0.45
CYP2D6 P10635 1/20 0.45
CYP2C9 P11712 1/20 0.45
ALOX12 P18054 1/20 0.45
CYP2C19 P33261 1/20 0.45
KMT2A Q03164 1/20 0.45
HSD17B10 Q99714 3/20 0.43
TSHR P16473 2/20 0.43
TDP1 Q9NUW8 2/20 0.43
CYP2A6 P11509 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2127807 0.91 ALDH1A1 (0.46) ALDH1A1TP53HPGDMAPK1MEN1
SCHEMBL18880015 0.90 HPRT1 (0.47) HPRT1SOS1ALDH1A1TP53HPGD
SCHEMBL19199345 0.89 HPRT1 (0.50) HPRT1SOS1ALDH1A1TP53HPGD
SCHEMBL19199346 0.88 HPRT1 (0.45) HPRT1SOS1ALDH1A1TP53HPGD
SCHEMBL23267572 0.88 CA12 (0.44) SOS1ALDH1A1TP53HPGDMAPK1
SCHEMBL27047246 0.88 HPRT1 (0.48) HPRT1SOS1ALDH1A1TP53HPGD
SCHEMBL19200316 0.87 HPRT1 (0.52) HPRT1SOS1ALDH1A1TP53HPGD
SCHEMBL16814673 0.87 CA12 (0.49) ALDH1A1TP53HPGDMAPK1CYP1A2
SCHEMBL30730878 0.87 KDM4E (0.49) SOS1ALDH1A1TP53HPGDMAPK1
SCHEMBL1321259 0.87 KDM4E (0.49) SOS1ALDH1A1TP53HPGDMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170222153-A1 ANTHRACENE DERIVATIVES, LUMINESCENT MATERIALS AND ORGANIC ELECTROLUMINESCENT DEVICES IDEMITSU KOSAN CO., LTD. (JP) 2017-08-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170222153-A1 ANTHRACENE DERIVATIVES, LUMINESCENT MATERIALS AND ORGANIC ELECTROLUMINESCENT DEVICES ANXA7, AAAS, ANXA1 HPRT1 549/4885SOS1 1101/4885ALDH1A1 1238/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.